Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
- PMID: 20808628
- PMCID: PMC2922663
- DOI: 10.4103/0974-2069.58317
Digoxin in management of heart failure in children: Should it be continued or relegated to the history books?
Conflict of interest statement
Similar articles
-
Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.J Am Coll Cardiol. 1998 Sep;32(3):686-92. doi: 10.1016/s0735-1097(98)00302-7. J Am Coll Cardiol. 1998. PMID: 9741512 Clinical Trial.
-
Clinical Use of Digitalis: A State of the Art Review.Am J Cardiovasc Drugs. 2018 Dec;18(6):427-440. doi: 10.1007/s40256-018-0292-1. Am J Cardiovasc Drugs. 2018. PMID: 30066080
-
Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.Drugs. 1992 May;43(5):637-50. doi: 10.2165/00003495-199243050-00002. Drugs. 1992. PMID: 1379144 Review.
-
Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.J Am Coll Cardiol. 1993 Oct;22(4):955-62. doi: 10.1016/0735-1097(93)90403-n. J Am Coll Cardiol. 1993. PMID: 8409069 Clinical Trial.
-
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.N Engl J Med. 1993 Jul 1;329(1):1-7. doi: 10.1056/NEJM199307013290101. N Engl J Med. 1993. PMID: 8505940 Clinical Trial.
Cited by
-
Medical Therapies for Heart Failure in Hypoplastic Left Heart Syndrome.J Cardiovasc Dev Dis. 2022 May 12;9(5):152. doi: 10.3390/jcdd9050152. J Cardiovasc Dev Dis. 2022. PMID: 35621863 Free PMC article.
-
A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population.Br J Clin Pharmacol. 2020 Jul;86(7):1267-1280. doi: 10.1111/bcp.14272. Epub 2020 Apr 1. Br J Clin Pharmacol. 2020. PMID: 32153059 Free PMC article.
-
Pediatric heart failure: Current approach and treatment.JHLT Open. 2025 Jun 27;9:100331. doi: 10.1016/j.jhlto.2025.100331. eCollection 2025 Aug. JHLT Open. 2025. PMID: 40697906 Free PMC article.
-
Repurposing of NKA inhibitors ('cardiac glycosides'): a critical analysis.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 18. doi: 10.1007/s00210-025-04443-x. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40679588
-
Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.J Cardiovasc Dev Dis. 2022 Jun 26;9(7):201. doi: 10.3390/jcdd9070201. J Cardiovasc Dev Dis. 2022. PMID: 35877563 Free PMC article. Review.
References
-
- Withering W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Willius FA, Keys TE, editors. Classics of Cardiology. New York NY: Dover Publications Inc; 1941. pp. 231–52.
-
- Paul JH, Ralph AK. Digitalis. Circulation. 1999;99:1265–70. - PubMed
-
- Rahimatoola SH, Tak T. The use of digitalis in heart failure. Curr Probl Cardiol. 1996;21:781–6. - PubMed
-
- Gunn VL, Nechyba C. The Harriet Lane Handbook. A manual for Pediatric House Officers. 16th ed. Philadelphia: Mosby Inc; 2002. pp. 747–8.
-
- Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, et al. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay. Pharmacotherapy. 1997;17:584–90. - PubMed